Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX
· Real-Time Price · USD
0.73
0.03 (4.29%)
At close: Aug 14, 2025, 3:52 PM
0.75
2.81%
Pre-market: Aug 15, 2025, 08:45 AM EDT
Context Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 18.95K | 18.95K | 18.95K | 18.95K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 2.57K | 2.57K | 2.57K | 2.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -2.57K | -5.14K | 11.25K | 8.16K | 7.53K | 6.91K | -9.48K | -9.58K | -6.39K | -3.19K | -3.19K | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -38.3M | -31.63M | -29.92M | -32.55M | -20.02M | -22.23M | -25.07M | -22.02M | -19.89M | -18.6M | -15.38M | -14.59M | -12.11M | -13.13M | -10.53M | -8.2M | -7.29M | -2.91M |
Interest Income | 4.07M | 4.01M | 3.2M | 2.46M | 1.51M | 960.78K | 1.16M | 939.26K | 841.06K | 569.08K | 219.41K | 219.41K | 27.16K | 5.86K | n/a | n/a | n/a | n/a |
Pretax Income | -34.21M | -27.64M | -26.73M | -30.15M | -18.57M | -21.32M | -23.96M | -20.75M | -18.73M | -17.71M | -14.84M | -14.37M | -11.96M | -13M | -10.46M | -8.15M | -7.58M | 4.93M |
Net Income | -34.21M | -27.64M | -26.73M | -30.15M | -18.57M | -21.32M | -23.96M | -20.75M | -18.73M | -17.71M | -14.84M | -14.37M | -11.96M | -13M | -10.46M | -8.15M | -7.58M | 4.93M |
Selling & General & Admin | 7.66M | 7.43M | 7.22M | 7.05M | 6.87M | 7M | 7.29M | 7.39M | 7.67M | 7.83M | 7.79M | 7.85M | 6.71M | 5.32M | 3.63M | 2.01M | 1.36M | 1.04M |
Research & Development | 30.64M | 24.19M | 22.7M | 25.48M | 13.14M | 15.22M | 17.78M | 14.63M | 12.22M | 10.28M | 7.09M | 6.24M | 4.9M | 4.72M | 3.81M | 3.11M | 2.84M | 1.87M |
Other Expenses | 2.75K | -3.35K | n/a | -64.15K | -48.78K | -54.91K | -55.57K | 5.83K | -8.01K | 504.22K | 500.29K | 500.02K | 498.49K | 3.09M | 3.09M | 3.09M | 3.09M | 1.94K |
Operating Expenses | 38.3M | 31.63M | 29.92M | 32.54M | 20.02M | 22.22M | 25.07M | 22.02M | 19.89M | 18.61M | 15.38M | 14.59M | 12.11M | 13.13M | 10.53M | 8.2M | 7.29M | 2.91M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.26K | 1.57K | 64.56K | 158.99K | 252.94K | 408.13K |
Selling & Marketing Expenses | n/a | -2.57K | -5.14K | -7.7K | -7.7K | -5.14K | -2.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 28.55M | 31.64M | 29.93M | 32.55M | 20.03M | 22.23M | 25.07M | 22.02M | 19.89M | 18.61M | 15.38M | 14.59M | 12.11M | 13.13M | 10.53M | 8.2M | 7.29M | 2.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -21.3K | -31.79K | -31.79K | -30.53K | -9.23K | 1.26K | 1.26K | n/a | n/a |
Shares Outstanding (Basic) | 95.19M | 95.19M | 58.42M | 80.48M | 54.96M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 10.21M | 361K | 6.88M | 10.21M |
Shares Outstanding (Diluted) | 95.19M | 95.19M | 58.42M | 80.48M | 54.96M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 15.97M | 10.21M | 361.07K | 6.88M | 10.21M |
EPS (Basic) | -0.42 | -0.37 | -0.55 | -0.91 | -1.06 | -1.33 | -1.5 | -1.3 | -1.17 | -1.11 | -0.93 | -1.01 | -0.98 | -1.46 | -1.33 | -1.1 | -0.98 | 1.46 |
EPS (Diluted) | -0.42 | -0.37 | -0.55 | -0.91 | -1.06 | -1.33 | -1.5 | -1.3 | -1.17 | -1.11 | -0.93 | -1.01 | -0.98 | -1.46 | -1.33 | -1.1 | -0.98 | 1.46 |
EBITDA | -38.29M | -31.62M | -29.91M | -32.54M | -20.02M | -22.22M | -25.06M | -22.01M | -19.88M | -18.09M | -14.87M | -14.09M | -11.61M | -10.04M | -7.44M | -5.04M | -4.12M | 5.45M |
EBIT | -28.54M | -31.63M | -29.92M | -32.55M | -20.03M | -22.23M | -25.07M | -22.02M | -19.89M | -18.11M | -14.88M | -14.09M | -11.61M | -10.04M | -7.44M | -5.04M | -4.25M | 5.32M |
Depreciation & Amortization | 9.8K | 12.37K | 10.88K | 10.52K | 10.79K | 11.42K | 12.04K | 12.67K | 12.77K | 12.46K | 9.27K | 6.07K | 2.88K | 1.94M | 2.78M | 2.78M | 2.78M | 840.32K |